{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:57Z","timestamp":1786119177641,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1097\/ico.0b013e318033bd25","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T00:35:33Z","timestamp":1236213333000},"page":"193-195","source":"Crossref","is-referenced-by-count":30,"title":["Topical Cyclosporine A in the Treatment of Superior Limbic Keratoconjunctivitis"],"prefix":"10.1097","volume":"27","author":[{"given":"Afsun","family":"Sahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Irkec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210204","first-page":"25","article-title":"Superior limbic keratoconjunctivitis.","volume":"42","author":"Theodore","year":"1963","journal-title":"Ear Nose Throat J"},{"key":"R2-12-20210204","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/eye.1989.26","article-title":"Superior limbic keratoconjunctivitis (SLK).","volume":"3","author":"Nelson","year":"1989","journal-title":"Eye"},{"key":"R3-12-20210204","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1442-9071.2000.00284.x","article-title":"Superior limbic keratoconjunctivitis: multifactorial mechanical pathogenesis.","volume":"28","author":"Cher","year":"2000","journal-title":"Clin Experiment Ophthalmol"},{"key":"R4-12-20210204","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/archopht.1983.01040020629032","article-title":"Superior limbic keratoconjunctivitis.","volume":"101","author":"Theodore","year":"1983","journal-title":"Arch Ophthalmol"},{"key":"R5-12-20210204","first-page":"341","article-title":"Further observations on superior limbic keratoconjunctivitis.","volume":"71","author":"Theodore","year":"1967","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"R6-12-20210204","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0021-5155(99)00021-0","article-title":"TGF-beta 2, tenascin, and integrin beta 1 expression in superior limbic keratoconjunctivitis.","volume":"43","author":"Matsuda","year":"1999","journal-title":"Jpn J Ophthalmol"},{"key":"R7-12-20210204","first-page":"555","article-title":"Superior limbic keratoconjunctivitis.","volume":"92","author":"Wright","year":"1972","journal-title":"Trans Ophthalmol Soc UK"},{"key":"R8-12-20210204","first-page":"129","article-title":"Treatment of superior limbic keratoconjunctivitis with topical cromolyn sodium.","volume":"19","author":"Confino","year":"1987","journal-title":"Ann Ophthalmol"},{"key":"R9-12-20210204","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0002-9394(14)72177-4","article-title":"Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis.","volume":"120","author":"Grutzmacher","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"R10-12-20210204","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00003226-200211000-00009","article-title":"Ketotifen fumarate treatment of superior limbic keratoconjunctivitis.","volume":"21","author":"Udell","year":"2002","journal-title":"Cornea"},{"key":"R11-12-20210204","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1001\/archopht.1982.01030040912008","article-title":"Use of pressure patching and soft contact lenses in superior limbic keratoconjunctivitis.","volume":"100","author":"Mondino","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"R12-12-20210204","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0002-9394(88)90245-0","article-title":"Vitamin A eyedrops for superior limbic keratoconjunctivitis.","volume":"105","author":"Ohashi","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"R13-12-20210204","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00003226-200111000-00006","article-title":"Treatment of superior limbic keratoconjunctivitis by application of autologous serum.","volume":"20","author":"Goto","year":"2001","journal-title":"Cornea"},{"key":"R14-12-20210204","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/00006324-199810000-00015","article-title":"Lacrimal punctal occlusion therapy for the treatment of superior limbic keratoconjunctivitis.","volume":"75","author":"Kabat","year":"1998","journal-title":"Optom Vis Sci"},{"key":"R15-12-20210204","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0002-9394(14)71647-2","article-title":"Lacrimal punctal occlusion for the treatment of superior limbic keratoconjunctivitis.","volume":"124","author":"Yang","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"R16-12-20210204","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0161-6420(84)34207-5","article-title":"Conjunctival resection for superior limbic keratoconjunctivitis.","volume":"91","author":"Passons","year":"1984","journal-title":"Ophthalmology"},{"key":"R17-12-20210204","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0161-6420(86)33766-7","article-title":"Treatment of superior limbic keratoconjunctivitis by thermocauterization of the superior bulbar conjunctiva.","volume":"93","author":"Udell","year":"1986","journal-title":"Ophthalmology"},{"key":"R18-12-20210204","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/S0161-6420(03)00538-4","article-title":"Topical cyclosporine A 0.5% as a possible new treatment for superior limbic keratoconjunctivitis.","volume":"110","author":"Perry","year":"2003","journal-title":"Ophthalmology"},{"key":"R19-12-20210204","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(78)91970-0","article-title":"Cyclosporin A in patients receiving renal allografts from cadaver donors.","volume":"2","author":"Calne","year":"1978","journal-title":"Lancet"},{"key":"R20-12-20210204","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0039-6257(86)90035-4","article-title":"Cyclosporine A: immunology, pharmacology and therapeutic uses.","volume":"31","author":"Nussenblatt","year":"1986","journal-title":"Surv Ophthalmol"},{"key":"R21-12-20210204","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00003226-199311000-00004","article-title":"Immunological analysis and treatment of Moorens ulcer with cyclosporin A applied topically.","volume":"12","author":"Zhao","year":"1993","journal-title":"Cornea"},{"key":"R22-12-20210204","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0002-9394(14)70704-4","article-title":"Topical cyclosporine therapy for ulcerative keratitis associated with rheumatoid arthritis.","volume":"109","author":"Liegner","year":"1990","journal-title":"Am J Ophthalmol"},{"key":"R23-12-20210204","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s004170050204","article-title":"Topical cyclosporin A in Thygesons superficial punctate keratitis.","volume":"237","author":"Reinhard","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R24-12-20210204","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","article-title":"Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group.","volume":"107","author":"Stevenson","year":"2000","journal-title":"Ophthalmology"},{"key":"R25-12-20210204","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease.","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"R26-12-20210204","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/eye.1997.126","article-title":"A comparative approach to topical cyclosporine therapy.","volume":"11","author":"Williams","year":"1997","journal-title":"Eye"},{"key":"R27-12-20210204","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0161-6420(91)32069-4","article-title":"Topical cyclosporine in vernal keratoconjunctivitis.","volume":"98","author":"Bleik","year":"1991","journal-title":"Ophthalmology"},{"key":"R28-12-20210204","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/eye.1997.14","article-title":"Topical cyclosporine A 2% in the treatment of vernal keratoconjunctivitis.","volume":"11","author":"Mendicute","year":"1997","journal-title":"Eye"},{"key":"R29-12-20210204","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9394(14)77061-8","article-title":"Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis.","volume":"110","author":"Secchi","year":"1990","journal-title":"Am J Ophthalmol"},{"key":"R30-12-20210204","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0161-6420(98)99043-1","article-title":"A randomized, placebo-controlled trial of topical cyclosporine A in steroid-dependent atopic keratoconjunctivitis.","volume":"105","author":"Hingorani","year":"1998","journal-title":"Ophthalmology"},{"key":"R31-12-20210204","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ophtha.2003.05.035","article-title":"A randomized trial of topical cyclosporine 0.05% in topical steroid-resistant atopic keratoconjunctivitis.","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"},{"key":"R32-12-20210204","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0002-9394(89)90216-X","article-title":"Immunohistologic findings and results of treatment with cyclosporine in ligneous conjunctivitis.","volume":"107","author":"Holland","year":"1989","journal-title":"Am J Ophthalmol"},{"key":"R33-12-20210204","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0161-6420(89)32756-4","article-title":"Topical cyclosporine in high-risk corneal transplants.","volume":"96","author":"Belin","year":"1989","journal-title":"Ophthalmology"},{"key":"R34-12-20210204","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3109\/02713689609017652","article-title":"Cytokeratin and proliferative cell nuclear antigen expression in superior limbic keratoconjunctivitis.","volume":"15","author":"Matsuda","year":"1996","journal-title":"Curr Eye Res"},{"key":"R35-12-20210204","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1001\/archopht.119.10.1512","article-title":"Effects of cyclosporine A on human conjunctival fibroblasts.","volume":"119","author":"Leonardi","year":"2001","journal-title":"Arch Ophthalmol"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003226-200802000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:55:23Z","timestamp":1786038923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003226-200802000-00012"}},"subtitle":["A Long-Term Follow-Up"],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e318033bd25","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}